Biomaterials (B) is a scholarly journal dedicated to publishing research in the field of Materials Science. Elsevier is the publisher of this esteemed journal. The P-ISSN assigned to Biomaterials is 0142-9612 and its abbreviated form is Biomaterials..
Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.
|Journal title||Biomaterials (B)|
|Editor-in-chief||Professor Kam Leong, PhD|
|Subject Category||Materials Science|
Biomaterials Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Biomaterials Journal is Biomaterials..
The Ranking of Biomaterials in 2023 is 752. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Impact Factor of Biomaterials in 2023 is 14. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The SCImago of Biomaterials in 2023 is 2.716. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Acceptance Rate of Biomaterials in 2023 is 14%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.
The H-Index of Biomaterials in 2023 is 418. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Quartile of Biomaterials is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Biomaterials is indexed in (Indexing details)
|PubMed||Scopus||Web of Science||UGC||Embase||DOAJ|
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
The Editor-in-chief of Biomaterials is Professor Kam Leong, PhD
Biomaterials Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of Biomaterials is 4740 USD
Biomaterials Call for paper : Biomaterials invites original research contributions for consideration of publication in Biomaterials journal.
Journal seeking submissions in the broad areas of Materials Science that align with journal's focus on Materials Science.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Biomaterials involves the following steps:
Yes, the Biomaterials journal is indexed in PubMed.
Yes, the Biomaterials journal is indexed in Scopus.
Yes, the Biomaterials journal is indexed in UGC.
No, the Biomaterials journal is not indexed in Index copernicus.
No, Biomaterials journal is not a predatory journal.
The Impact Factor of the Biomaterials is 14.
The Ranking of the Biomaterials is 752.
Yes the Biomaterials (B) journal is a peer-reviewed journal.
Yes the Biomaterials journal is a peer-reviewed journal and good to publish your paper.
Yes, Biomaterials is a open access (Hybrid) journal.